Argentine laboratory raises funds to develop Sputnik vaccine

Pharmaceutical company Laboratorios Richmond has raised US$85 million to develop Russia’s Sputnik V covid-19 vaccine in Argentina, launching a public offering that called on local counsel from Nicholson y Cano Abogados and Tavarone, Rovelli, Salim & Miani.


Get unlimited access to all Latin Lawyer content